Fujihara, Kazuo
Fukushima Medical University · Southern TOHOKU Research Institute for Neuroscience
16 papers on CoChatORCID 0000-0002-3096-4156
Most cited papers
- Verified
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria
Polman, C. H., Reingold, S. C., Banwell, B., Clanet, M., Cohen, J. A., Filippi, M., Fujihara, K., Havrdova, E., Hutchinson, M., Kappos, L., et al. (2011) · Annals of Neurology
Multiple Sclerosis Research StudiesClinical Reasoning and Diagnostic Skills
Cited by 9,802
- Verified
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
Thompson, A. J., Banwell, B. L., Barkhof, F., Carroll, W. M., Coetzee, T., Comi, G., Correale, J., Fazekas, F., Filippi, M., Freedman, M. S., et al. (2018) · The Lancet Neurology
Multiple Sclerosis Research StudiesClinical Reasoning and Diagnostic Skills
Cited by 8,167
- Verified
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
Wingerchuk, D. M., Banwell, B., Bennett, J. L., Cabre, P., Carroll, W., Chitnis, T., de Seze, J., Fujihara, K., Greenberg, B., Jacob, A., et al. (2015) · Neurology
Multiple Sclerosis Research StudiesPeripheral Neuropathies and Disorders
Cited by 4,649
- Verified
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
Lennon, V. A., Wingerchuk, D. M., Kryzer, T. J., Pittock, S. J., Lucchinetti, C. F., Fujihara, K., Nakashima, I., & Weinshenker, B. G. (2004) · The Lancet
Multiple Sclerosis Research StudiesAutoimmune Neurological Disorders and Treatments
Cited by 3,239
- Verified
Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders
Sato, D. K., Callegaro, D., Lana-Peixoto, M. A., Waters, P. J., Jorge, F. M. D. H., Takahashi, T., Nakashima, I., Apostolos-Pereira, S. L., Talim, N., Simm, R. F., et al. (2014) · Neurology
Multiple Sclerosis Research StudiesPeripheral Neuropathies and Disorders
Cited by 850
- Verified
Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial
Cree, B. A. C., Bennett, J. L., Kim, H. J., Weinshenker, B. G., Pittock, S. J., Wingerchuk, D. M., Fujihara, K., Paul, F., Cutter, G. R., Marignier, R., et al. (2019) · The Lancet
Multiple Sclerosis Research StudiesPeripheral Neuropathies and Disorders
Cited by 756
- Verified
Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria
Montalban, X., Lebrun-Frénay, C., Oh, J., Arrambide, G., Moccia, M., Pia Amato, M., Amezcua, L., Banwell, B., Bar-Or, A., Barkhof, F., et al. (2025) · The Lancet Neurology
Multiple Sclerosis Research StudiesPolyomavirus and related diseases
Cited by 551
- Verified
Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan
Kitley, J., Leite, M. I., Nakashima, I., Waters, P., McNeillis, B., Brown, R., Takai, Y., Takahashi, T., Misu, T., Elsone, L., et al. (2012) · Brain
Multiple Sclerosis Research StudiesPeripheral Neuropathies and Disorders
Cited by 438
- Verified
Diagnosis and classification of optic neuritis
Petzold, A., Fraser, C. L., Abegg, M., Alroughani, R., Alshowaeir, D., Alvarenga, R., Andris, C., Asgari, N., Barnett, Y., Battistella, R., et al. (2022) · The Lancet Neurology
Multiple Sclerosis Research StudiesOcular Diseases and Behçet’s Syndrome
Cited by 330
- Verified
Treatment of neuromyelitis optica: review and recommendations
Kimbrough, D. J., Fujihara, K., Jacob, A., Lana-Peixoto, M. A., Isabel Leite, M., Levy, M., Marignier, R., Nakashima, I., Palace, J., de Seze, J., et al. (2012) · Multiple Sclerosis and Related Disorders
Multiple Sclerosis Research StudiesPeripheral Neuropathies and Disorders
Cited by 260
- Verified
Neuromyelitis optica and multiple sclerosis: Seeing differences through optical coherence tomography
Bennett, J., de Seze, J., Lana-Peixoto, M., Palace, J., Waldman, A., Schippling, S., Tenembaum, S., Banwell, B., Greenberg, B., Levy, M., et al. (2015) · Multiple Sclerosis Journal
Multiple Sclerosis Research StudiesGlaucoma and retinal disorders
Cited by 252
- Verified
Myelin injury without astrocytopathy in neuroinflammatory disorders with MOG antibodies
Kaneko, K., Sato, D. K., Nakashima, I., Nishiyama, S., Tanaka, S., Marignier, R., Hyun, J.-W., Oliveira, L. M. D., Reindl, M., Seifert-Held, T., et al. (2016) · Journal of Neurology, Neurosurgery & Psychiatry
Multiple Sclerosis Research StudiesAutoimmune Neurological Disorders and Treatments
Cited by 106
- Verified
Pathogenic T cell responses against aquaporin 4
Pohl, M., Fischer, M.-T., Mader, S., Schanda, K., Kitic, M., Sharma, R., Wimmer, I., Misu, T., Fujihara, K., Reindl, M., et al. (2011) · Acta Neuropathologica
Multiple Sclerosis Research StudiesPeripheral Neuropathies and Disorders
Cited by 98
- Verified
Leukoencephalopathy in HTLV-I-associated myelopathy/tropical spastic paraparesis: MRI analysis and a two year follow-up study after corticosteroid therapy
Kira, J.-I., Fujihara, K., Itoyama, Y., Goto, I., & Hasuo, K. (1991) · Journal of the Neurological Sciences
T-cell and Retrovirus StudiesInfectious Diseases and Tuberculosis
Cited by 96
- Verified
Aquaporin 4-specific T cells and NMO-IgG cause primary retinal damage in experimental NMO/SD
Zeka, B., Hastermann, M., Kaufmann, N., Schanda, K., Pende, M., Misu, T., Rommer, P., Fujihara, K., Nakashima, I., Dahle, C., et al. (2016) · Acta Neuropathologica Communications
Multiple Sclerosis Research StudiesOcular Diseases and Behçet’s Syndrome
Cited by 65
- Verified
Multiple sclerosis in Japan appears to be a milder disease compared to the UK
Piccolo, L., Kumar, G., Nakashima, I., Misu, T., Kong, Y., Wakerley, B., Ryan, S., Cavey, A., Fujihara, K., & Palace, J. (2015) · Journal of Neurology
Multiple Sclerosis Research StudiesPolyomavirus and related diseases
Cited by 57
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free